A regulatory perspective on the development of gene therapy for Parkinson's disease

被引：2
|
作者：
Havert, Michael B. [1 ]
机构：
[1] US FDA, Ctr Biol Evaluat & Review, Off Cellular Tissue & Gene Therapies, Div Cellular & Gene Therapies, Rockville, MD 20852 USA
来源：
EXPERIMENTAL NEUROLOGY | 2008年 / 209卷 / 01期
关键词：
D O I：
10.1016/j.expneurol.2007.08.010
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：48 / 50
页数：3
相关论文
共 50 条
  • [21] Scientific rationale for the development of gene therapy strategies for Parkinson's disease
    Bjorklund, Tomas
    Kirik, Deniz
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 703 - 713
  • [22] Gene therapy for Parkinson's and Huntington's disease
    Kordower, JH
    McBride, J
    MOVEMENT DISORDERS, 2004, 19 : S8 - S8
  • [23] At last, a gene therapy for Parkinson's disease?
    Hutchinson, Michael
    LANCET NEUROLOGY, 2011, 10 (04): : 290 - 291
  • [24] Gene Therapy for Parkinson's Disease, An Update
    Axelsen, Tobias M.
    Woldbye, David P. D.
    JOURNAL OF PARKINSONS DISEASE, 2018, 8 (02) : 195 - 215
  • [25] An Update on Gene Therapy in Parkinson's Disease
    Witt, Jennifer
    Marks, William J., Jr.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (04) : 362 - 370
  • [26] Gene therapy approaches for Parkinson's disease
    Aebischer, P
    Pralong, W
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 8 - 8
  • [27] Dosing Gene Therapy for Parkinson's Disease
    Natalie Dewitt
    Nature Biotechnology, 1999, 17 (4) : 318 - 318
  • [28] Prospects for gene therapy in Parkinson's disease
    Freese, A
    Stern, M
    Kaplitt, MG
    OConnor, WM
    Abbey, MV
    OConnor, MJ
    During, MJ
    MOVEMENT DISORDERS, 1996, 11 (05) : 469 - 488
  • [29] Towards gene therapy for Parkinson's disease
    Palfi, Stephane
    LANCET NEUROLOGY, 2008, 7 (05): : 375 - 376
  • [30] Gene therapy for Parkinson's disease models
    Faial, Tiago
    NATURE GENETICS, 2024, 56 (01) : 8 - 8
12345